EGR genes as targets for the diagnosis and treatment of schizophrenia

Details for Australian Patent Application No. 2004255223 (hide)

Owner Massachusetts Institute of Technology Rockefeller University The Trustees of Columbia University in the City of New York

Inventors Gogos, Joseph A.; Karayiorgou, Maria; Tonegawa, Susumu; Gerber, David J.; Hall, Diana

Agent Davies Collison Cave

Pub. Number AU-A-2004255223

PCT Pub. Number WO2005/004702

Priority 60/484,043 30.06.03 US

Filing date 30 June 2004

Wipo publication date 20 January 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/004702 Priority application(s): WO2005/004702

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255225-Self-crosslinkable poly(caprolactone fumarate)

2004255218-Formulations for coated microprojections containing non-volatile counterions